103 related articles for article (PubMed ID: 9489096)
1. Locally applied transdermal nitrate patches for the treatment of ischaemic rest pain.
Fletcher S; Wright M; Wilkinson A; Farr M; Sellars L
Int J Clin Pract; 1997; 51(5):324-5. PubMed ID: 9489096
[TBL] [Abstract][Full Text] [Related]
2. Two randomised and placebo-controlled studies of an oral prostacyclin analogue (Iloprost) in severe leg ischaemia. The Oral Iloprost in severe Leg Ischaemia Study Group.
Eur J Vasc Endovasc Surg; 2000 Oct; 20(4):358-62. PubMed ID: 11038148
[TBL] [Abstract][Full Text] [Related]
3. Effect of transdermal nitroglycerin on inflammatory mediators in patients with peripheral atherosclerotic vascular disease.
de Berrazueta JR; Sampedro I; Garcia-Unzueta MT; Llorca J; Bustamante M; Amado JA
Am Heart J; 2003 Oct; 146(4):E14. PubMed ID: 14564337
[TBL] [Abstract][Full Text] [Related]
4. Transdermal buprenorphine patches applied in a 4-day regimen versus a 3-day regimen: a single-site, Phase III, randomized, open-label, crossover comparison.
Likar R; Lorenz V; Korak-Leiter M; Kager I; Sittl R
Clin Ther; 2007 Aug; 29(8):1591-606. PubMed ID: 17919542
[TBL] [Abstract][Full Text] [Related]
5. Topical glyceryl trinitrate application in the treatment of chronic supraspinatus tendinopathy: a randomized, double-blinded, placebo-controlled clinical trial.
Paoloni JA; Appleyard RC; Nelson J; Murrell GA
Am J Sports Med; 2005 Jun; 33(6):806-13. PubMed ID: 15827365
[TBL] [Abstract][Full Text] [Related]
6. Transdermal buprenorphine in clinical practice--a post-marketing surveillance study in 13,179 patients.
Griessinger N; Sittl R; Likar R
Curr Med Res Opin; 2005 Aug; 21(8):1147-56. PubMed ID: 16083522
[TBL] [Abstract][Full Text] [Related]
7. Transdermal buprenorphine in the treatment of chronic pain: results of a phase III, multicenter, randomized, double-blind, placebo-controlled study.
Sorge J; Sittl R
Clin Ther; 2004 Nov; 26(11):1808-20. PubMed ID: 15639693
[TBL] [Abstract][Full Text] [Related]
8. [Post marketing surveillance study with an analgesic (transdermal buprenorphine patch) in patients with moderate to severe chronic pain].
Tschirner M; Ritzdorf I; Brünjes R
MMW Fortschr Med; 2008 Sep; 150 Suppl 3():142-8. PubMed ID: 19025217
[TBL] [Abstract][Full Text] [Related]
9. Topical nitroglycerin versus lateral internal sphincterotomy for chronic anal fissure: prospective, randomized trial.
Mishra R; Thomas S; Maan MS; Hadke NS
ANZ J Surg; 2005 Dec; 75(12):1032-5. PubMed ID: 16398803
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness and tolerability of the buprenorphine transdermal system in patients with moderate to severe chronic pain: a multicenter, open-label, uncontrolled, prospective, observational clinical study.
Muriel C; Failde I; Micó JA; Neira M; Sánchez-Magro I
Clin Ther; 2005 Apr; 27(4):451-62. PubMed ID: 15922818
[TBL] [Abstract][Full Text] [Related]
11. A Phase III study to assess the clinical utility of low-dose fentanyl transdermal system in patients with chronic nonmalignant pain.
Otis J; Rothman M
Curr Med Res Opin; 2006 Aug; 22(8):1493-501. PubMed ID: 16870074
[TBL] [Abstract][Full Text] [Related]
12. Resolution of peripheral artery catheter-induced ischemic injury following prolonged treatment with topical nitroglycerin ointment in a newborn: a case report.
Vasquez P; Burd A; Mehta R; Hiatt M; Hegyi T
J Perinatol; 2003 Jun; 23(4):348-50. PubMed ID: 12774147
[TBL] [Abstract][Full Text] [Related]
13. Resolution of peripheral tissue ischemia secondary to arterial vasospasm following treatment with a topical nitroglycerin device in two newborns: case reports.
Maffei G; Rinaldi M; Rinaldi G
J Perinat Med; 2006; 34(3):252. PubMed ID: 16602850
[No Abstract] [Full Text] [Related]
14. [The treatment of chronic fissure in ano with nitrate ointment].
Stassen LP; Schouten WR
Ned Tijdschr Geneeskd; 1999 Jan; 143(1):13-6. PubMed ID: 10086091
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, placebo-controlled trial of transdermal glyceryl trinitrate in ERCP: effects on technical success and post-ERCP pancreatitis.
Kaffes AJ; Bourke MJ; Ding S; Alrubaie A; Kwan V; Williams SJ
Gastrointest Endosc; 2006 Sep; 64(3):351-7. PubMed ID: 16923481
[TBL] [Abstract][Full Text] [Related]
16. A safe and effective method for converting patients from transdermal to intravenous fentanyl for the treatment of acute cancer-related pain.
Kornick CA; Santiago-Palma J; Schulman G; O'Brien PC; Weigand S; Payne R; Manfredi PL
Cancer; 2003 Jun; 97(12):3121-4. PubMed ID: 12784350
[TBL] [Abstract][Full Text] [Related]
17. Use of transdermal fentanyl without prior opioid stabilization in patients with cancer pain.
Tawfik MO; Bryuzgin V; Kourteva G;
Curr Med Res Opin; 2004 Mar; 20(3):259-67. PubMed ID: 15025835
[TBL] [Abstract][Full Text] [Related]
18. Equipotent doses of transdermal fentanyl and transdermal buprenorphine in patients with cancer and noncancer pain: results of a retrospective cohort study.
Sittl R; Likar R; Nautrup BP
Clin Ther; 2005 Feb; 27(2):225-37. PubMed ID: 15811486
[TBL] [Abstract][Full Text] [Related]
19. A painless treatment for patients undergoing Milligan-Morgan haemorrhoidectomy.
Di Vita G; Patti R; Arcara M; Petrone R; Davì V; Leo P
Ann Ital Chir; 2004; 75(4):471-4; discussion 474-5. PubMed ID: 15754699
[TBL] [Abstract][Full Text] [Related]
20. Transdermal fentanyl: informed prescribing is essential.
Ross JR; Quigley C
Eur J Pain; 2003; 7(5):481-3. PubMed ID: 12935801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
